Showing results (31-40 of 75) with videos related to
Sort By:
Pageof 8
Royal Society Open Science|January 25, 2021
Vitamin D and COVID-19: evidence and recommendations for supplementationGeorge Griffin, Martin Hewison, Julian Hopkin, et al.Clinical Medicine (London, England)|February 17, 2021
Perspective: Vitamin D supplementation prevents rickets and acute respiratory infections when given as daily maintenance but not as intermittent bolus: implications for COVID-19George Griffin, Martin Hewison, Julian Hopkin, et al.Clinical Medicine (London, England)|November 7, 2020
Preventing vitamin D deficiency during the COVID-19 pandemic: UK definitions of vitamin D sufficiency and recommended supplement dose are set too lowGeorge Griffin, Martin Hewison, Julian Hopkin, et al.European Journal of Gastroenterology & Hepatology|December 15, 2015
Comparative analysis of the influence of clinical factors including BMI on adalimumab and infliximab trough levelsAshley Bond, Rebecca Asher, Richard Jackson, et al.Journal of Clinical Medicine|February 13, 2025
A Treat-to-Target Approach in IBD: Contemporary Real-World Perspectives from an International SurveyMohmmed Tauseef Sharip, Biljana Brezina, Juan De La Revilla Negro, et al.Journal of Crohn'S & Colitis|April 24, 2024
Intravenous Versus Subcutaneous Infliximab in Inflammatory Bowel Disease: A Systematic Review and Meta-analysisJohn David Chetwood, Yvonne Tran, Sreedhar Subramanian, et al.Journal of Internal Medicine|July 7, 2022
Vitamin D and COVID-19-RevisitedSreedhar Subramanian, George Griffin, Martin Hewison, et al.Journal of Clinical Gastroenterology|August 18, 2025
Effectiveness of Switching From Intravenous to Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease: An individual participant data meta-analysisFraser Cummings, Philip J Smith, Mathurin Fumery, et al.Antimicrobial Agents and Chemotherapy|December 12, 2007
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to AntibioticsSreedhar Subramanian, Carol L Roberts, C Anthony Hart, et al.The Patient|November 9, 2021
Women's Willingness to Accept Risks of Medication for Inflammatory Bowel Disease During PregnancyTatyana Kushner, Angelyn Fairchild, F Reed Johnson, et al.Pageof 8